TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bioaxter Bioscience AB
Closing information (x1000 DKK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
3,477 |
| Financial expenses |
0
|
0
|
10 |
| Earnings before taxes |
-341
|
1,811
|
116 |
| EBITDA |
-267
|
1,886
|
944 |
| Total assets |
1,592
|
2,022
|
2,018 |
| Current assets |
1,494
|
1,845
|
1,178 |
| Current liabilities |
55
|
107
|
816 |
| Equity capital |
1,538
|
1,915
|
1,085 |
| - share capital |
36
|
37
|
36 |
| Employees (average) |
1
|
1
|
4 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
96.6%
|
94.7%
|
53.8% |
| Turnover per employee |
0
|
0
|
869 |
| Profit as a percentage of turnover | 3.3% | ||
| Return on assets (ROA) |
-21.4%
|
89.6%
|
6.2% |
| Current ratio |
2716.4%
|
1724.3%
|
144.4% |
| Return on equity (ROE) |
-22.2%
|
94.6%
|
10.7% |
| Change turnover |
0
|
-3,600
|
-376 |
| Change turnover % |
-100%
|
-10% | |
| Chg. No. of employees |
0
|
-3
|
0 |
| Chg. No. of employees % |
0%
|
-75%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.